Senior insider sale
DENALI THERAPEUTICS INC. — senior position signals high conviction
$266.1K
11.44K shares
What this filing means
THORNBERRY NANCY plans to sell 11.44K shares of DENALI THERAPEUTICS INC. valued at approximately $266.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001950047-26-009017
11.44K
Shares to sell
$266.1K
Approx. market value
11.44K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/8/2024
11.44KTotal acquired11.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/8/2024 | Restricted Stock Units N/A | 11.44K | — |
| Total | 11.44K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.44K
Market value
$266.1K
9/2/2026
Total
Units
11.44K
Value
$266.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2026 | 11.44K | $266.1K | NASDAQ | Planned |
| Total | 11.44K | $266.1K | ||